{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:05:31Z","timestamp":1774566331198,"version":"3.50.1"},"reference-count":16,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Ocular Immunology and Inflammation"],"published-print":{"date-parts":[[2026,3,16]]},"DOI":"10.1080\/09273948.2026.2633444","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:25:18Z","timestamp":1771287918000},"page":"719-722","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Epstein-Barr Virus-Associated Primary Vitreoretinal B-Cell Lymphoma in a Patient Receiving Tofacitinib and Methotrexate for Psoriatic Arthritis"],"prefix":"10.1080","volume":"34","author":[{"given":"Catherine","family":"Qin","sequence":"first","affiliation":[{"name":"Buckinghamshire Healthcare NHS Foundation Trust","place":["Aylesbury, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef","family":"Helmy","sequence":"additional","affiliation":[{"name":"Buckinghamshire Healthcare NHS Foundation Trust","place":["Aylesbury, UK"]},{"name":"Cairo University Faculty of Medicine","place":["Cairo, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Latasiewicz","sequence":"additional","affiliation":[{"name":"Buckinghamshire Healthcare NHS Foundation Trust","place":["Aylesbury, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambreen","family":"Kalhoro Tunio","sequence":"additional","affiliation":[{"name":"Buckinghamshire Healthcare NHS Foundation Trust","place":["Aylesbury, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-5409","authenticated-orcid":false,"given":"Dimitrios","family":"Kalogeropoulos","sequence":"additional","affiliation":[{"name":"Buckinghamshire Healthcare NHS Foundation Trust","place":["Aylesbury, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2018.12.008"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927"},{"key":"e_1_3_3_4_1","unstructured":"U.S. Food and Drug Administration. Fda requires warnings about increased risk of serious heart-related events cancer blood clots and death for JAK inhibitors that treat certain chronic inflammatory conditions. 2021. fda.gov. Accessed October 28 2025."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01583-x"},{"issue":"9","key":"e_1_3_3_6_1","first-page":"36","article-title":"Choosing treatment for primary vitreoretinal lymphoma","volume":"21","author":"Binkley E.","year":"2024","unstructured":"Binkley E. Choosing treatment for primary vitreoretinal lymphoma. Retinal Physician. 2024;21(9):36\u201344.","journal-title":"Retinal Physician"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44455-w"},{"key":"e_1_3_3_8_1","first-page":"334","article-title":"Epstein\u2013Barr virus\u2011positive iris diffuse large B\u2011cell lymphoma after keratoplasty: a case report","volume":"24","author":"Wang X","year":"2024","unstructured":"Wang X, Zhang L, Hao P, et al. Epstein\u2013Barr virus\u2011positive iris diffuse large B\u2011cell lymphoma after keratoplasty: a case report. BMC Ophthalmol. 2024;24:334.","journal-title":"BMC Ophthalmol"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9496173"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-023-03226-3"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082197"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01657-0"},{"issue":"10","key":"e_1_3_3_13_1","first-page":"6172","article-title":"Diagnosis of intraocular lymphoma by PCR analysis for immunoglobulin heavy chain gene rearrangement and EBV DNA","volume":"53","author":"Sugita S","year":"2012","unstructured":"Sugita S, Shimizu N, Watanabe K, et al. Diagnosis of intraocular lymphoma by PCR analysis for immunoglobulin heavy chain gene rearrangement and EBV DNA. Invest Ophthalmol Vis Sci. 2012;53(10):6172\u20136179.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_3_14_1","first-page":"102513","article-title":"Iatrogenic immunodeficiency\u2011associated lymphoproliferative disorder due to methotrexate: case report and literature review","volume":"67","author":"Derise N","year":"2021","unstructured":"Derise N, Boespflug O, Bouquet H, et al. Iatrogenic immunodeficiency\u2011associated lymphoproliferative disorder due to methotrexate: case report and literature review. Ann Med Surg (Lond). 2021;67:102513.","journal-title":"Ann Med Surg (Lond)"},{"issue":"6","key":"e_1_3_3_15_1","first-page":"801","article-title":"Association of Epstein\u2013Barr virus with regression after discontinuation of immunosuppressants in autoimmune disease\u2011associated LPDs","volume":"112","author":"Fujimoto K","year":"2020","unstructured":"Fujimoto K, Umino A, Ishikawa E, et al. Association of Epstein\u2013Barr virus with regression after discontinuation of immunosuppressants in autoimmune disease\u2011associated LPDs. Int J Hematol. 2020;112(6):801\u2013808.","journal-title":"Int J Hematol"},{"issue":"9","key":"e_1_3_3_16_1","first-page":"1256","article-title":"Comparative risk of cancer associated with JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a cohort study","volume":"80","author":"Desai RJ","year":"2021","unstructured":"Desai RJ, Pawar A, Weinblatt ME, Kim SC. Comparative risk of cancer associated with JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a cohort study. Ann Rheum Dis. 2021;80(9):1256\u20131262.","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000440646"}],"container-title":["Ocular Immunology and Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09273948.2026.2633444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:18:04Z","timestamp":1774541884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09273948.2026.2633444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,16]]}},"alternative-id":["10.1080\/09273948.2026.2633444"],"URL":"https:\/\/doi.org\/10.1080\/09273948.2026.2633444","relation":{},"ISSN":["0927-3948","1744-5078"],"issn-type":[{"value":"0927-3948","type":"print"},{"value":"1744-5078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}